Added to YB: 2025-06-17
Pitch date: 2025-06-13
DXRX.L [neutral]
Diaceutics PLC
+10.76%
current return
Author Info
Increasing Odds shares their investment journey in their newsletter. Sign up for the newsletter.
Company Info
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies.
Market Cap
GBP 106.1M
Pitch Price
GBP 1.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
133.72
P/E
-62.13
EV/Sales
2.94
Sector
Life Sciences Tools and Services
Category
growth
Exploring AIM: A-Z Part 8 - Diaceutics Plc
DXRX.L pass: £106m precision medicine commercialization provider with 50% recurring revenue. Growing strongly but unprofitable, expects PBT profitability in FY25. No debt. High-growth unprofitable software business may interest growth investors.
Read full article (1 min)